& Cadena, D
IV administration bypasses digestion, but this does not establish better clinical outcomes for general wellness, detoxification or longevity
When theres a shortage of a commercially available drug or when a patient requires a different formulation, pharmacies will compound the medication
Wegovy (semaglutide) is a GLP-1 receptor agonist that slows gastric emptying, potentially exacerbating pre-existing gastric conditions Common gastrointestinal side effects include nausea (44%), vomiting (24%), dyspepsia, abdominal pain, and constipation Gastritis is not listed as a recognised adverse effect in the UK Summary of Product Characteristics Patients with severe gastrointestinal disease or history of peptic ulcer disease should discuss risks with their prescriber before starting treatment Seek urgent medical advice for severe abdominal pain, vomiting blood, black stools, or persistent symptoms that do not improve Table of Contents Can Wegovy Cause Gastritis
Jonckheer MH, VanHaelst L, DeConinck F, Michotte Y
Medical professionals maintain high standards for treatment protocols and patient selection criteria based on comprehensive clinical guidelines